Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva

Mostrar otras versiones (1)

The coronavirus disease 2019 (COVID-19) pandemic has become an immense global health crisis. However, the lack of efficient and sensitive on-site testing methods limits early detection for timely isolation and intervention. Here, we present a quantitative and ultrasensitive in situ immunoassay techn...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuchao, Liu, Fei, Lee, Luke P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132547/
https://www.ncbi.nlm.nih.gov/pubmed/35613342
http://dx.doi.org/10.1126/sciadv.abn3481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132547/
https://www.ncbi.nlm.nih.gov/pubmed/35613342
http://dx.doi.org/10.1126/sciadv.abn3481

Ejemplares similares